Real-World Outcomes With Low-Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety. [PDF]
Gangadaran N +9 more
europepmc +1 more source
A case report focusing on diagnosis and intervention of chronic myeloid leukemia in blast crisis (acute megakaryoblastic leukemia subtype). [PDF]
Liu L +8 more
europepmc +1 more source
Chronic Myeloid Leukemia Harboring a Novel Four-Way Variant Translocation t(7;22;9;15)(p15;q11.2;q34.1;q22) With Cryptic Double Philadelphia Chromosomes. [PDF]
Kamigaki S, Ito M, Nakano S, Takagi N.
europepmc +1 more source
A case report of mixed-phenotype acute leukemia with atypical BCR::ABL1 e13a3 fusion gene. [PDF]
Zhou Y +8 more
europepmc +1 more source
Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. [PDF]
Yu L, Jiang Q.
europepmc +1 more source
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]
Avinery L +4 more
europepmc +1 more source
Pediatric chronic myeloid leukemia: A decade of clinical experience at the NBK specialized hospital for children. [PDF]
Bourusly M +5 more
europepmc +1 more source
Efficacy and safety of flumatinib in adults with Ph-positive ALL: a prospective observational study. [PDF]
Xu J +7 more
europepmc +1 more source

